PT-141 (Bremelanotide) 10mg

Product Overview

PT-141, scientifically known as Bremelanotide, is a synthetic cyclic peptide that belongs to the melanocortin receptor-targeting compound class. Originally derived from the linear peptide Melanotan II, PT-141 was structurally modified to produce a stable, cyclic heptapeptide with a distinct pharmacological profile of interest to the research community. Revo Peptide offers PT-141 (Bremelanotide) 10mg as a premium-grade research reagent, manufactured to rigorous quality standards and supplied as a lyophilized white powder for laboratory investigation. Researchers seeking to buy PT-141 online will find Revo Peptide’s offering competitively priced, analytically verified, and reliably fulfilled.

Peptide Structure & Amino Acid Sequence

PT-141 is a cyclic heptapeptide with the following confirmed amino acid sequence:

• Sequence: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH
• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
• Molecular Weight: Approximately 1025.16 g/mol

The cyclic architecture of PT-141 distinguishes it from its linear predecessors, contributing to its structural rigidity and enhanced stability under standard laboratory conditions. The incorporation of D-Phe at position 4 and the N-acetyl-norleucine (Ac-Nle) cap are key structural features that define its receptor-binding profile as documented in published research literature.

Chemical & Physical Characteristics

• Appearance: White lyophilized powder
• Solubility: Soluble in water or 1% acetic acid
• CAS Number: 189691-06-3
• Peptide Purity: ≥99%
• Storage Stability: Stable under recommended cold-chain conditions

The lyophilized format ensures maximum shelf stability during transport and storage. The white powder form is consistent across production batches, and solubility in aqueous or mildly acidic solutions makes PT-141 compatible with a wide range of in vitro laboratory protocols.

Purity & Analytical Verification (HPLC & MS)

Every batch of PT-141 (Bremelanotide) 10mg supplied by Revo Peptide undergoes rigorous analytical testing prior to release. Purity is confirmed at ≥99% using high-performance liquid chromatography (HPLC), and molecular identity is validated through mass spectrometry (MS). These dual analytical methods ensure that each vial meets strict research-grade specifications, providing scientists and laboratory professionals with the confidence needed for reproducible experimental outcomes. Certificate of Analysis (CoA) documentation is available upon request, reflecting our commitment to transparency and scientific integrity.

Quality Control & Lyophilization Integrity

Revo Peptide applies stringent quality control protocols throughout the manufacturing and packaging process. PT-141 is produced under controlled synthesis conditions and lyophilized using validated freeze-drying procedures that preserve peptide structure and bioactivity at the molecular level. Each vial is sealed under inert atmosphere conditions to minimize oxidative degradation. Batch-to-batch consistency is maintained through standardized production workflows and independent analytical verification, ensuring that researchers receive a reliable, high-integrity reagent with every order.

Safety, Handling & Laboratory Precautions

PT-141 (Bremelanotide) 10mg is supplied exclusively for qualified laboratory and research use. Personnel handling this compound should adhere to standard laboratory safety protocols, including the use of appropriate personal protective equipment (PPE) such as gloves, lab coat, and eye protection. This compound should be handled in a properly ventilated laboratory environment. Avoid inhalation of powder during weighing or reconstitution. Dispose of all materials in compliance with local institutional and regulatory waste disposal guidelines. This product is not intended for human or veterinary use, and must not be used in clinical, diagnostic, or consumptive settings.

Reconstitution, Packaging & Storage

PT-141 is supplied as a lyophilized powder in a sealed research-grade vial. For laboratory reconstitution purposes, sterile water or a 1% acetic acid solution is recommended as a suitable solvent based on the compound’s established solubility profile. Reconstituted solutions should be handled according to institutional biosafety and research protocols. For optimal preservation of lyophilized material, store at -20°C in a dry, dark environment away from repeated freeze-thaw cycles. Once reconstituted, solutions should be used promptly or stored at 4°C for short-term laboratory use only.

Intended Research Use & Market Positioning

PT-141 (Bremelanotide) is of significant interest to researchers investigating melanocortin receptor biology, neuropeptide signaling pathways, and related fields of pharmacological science. As a melanocortin receptor agonist with documented affinity for MC3R and MC4R subtypes, it serves as a valuable tool compound in receptor binding studies, in vitro assay development, and comparative peptide pharmacology research. Revo Peptide positions PT-141 as a best-in-class research reagent for academic institutions, contract research organizations, and independent laboratory scientists seeking a reliable, high-purity compound at a competitive price.

Ordering, Availability & Fulfillment

Revo Peptide offers PT-141 (Bremelanotide) 10mg for sale online with streamlined ordering, competitive pricing, and reliable dispatch. Bulk purchasing options are available with tiered volume discounts applied automatically at checkout, making Revo Peptide an ideal source for laboratories requiring consistent supply. Orders are processed promptly and shipped with appropriate cold-chain packaging to preserve product integrity during transit. Our customer support team is available to assist with order inquiries, CoA requests, and fulfillment questions. Order now and experience the Revo Peptide difference in research-grade quality and service.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. PT-141 (Bremelanotide) 10mg is sold exclusively as a laboratory research reagent. Revo Peptide makes no representations regarding the suitability of this compound for any application outside of controlled scientific research. All purchasers are solely responsible for ensuring that their acquisition, handling, and use of this product complies with all applicable local, national, and international laws and regulations. This product has not been evaluated or approved by any regulatory authority for therapeutic, prophylactic, or diagnostic use in humans or animals.